Sun Pharmaceutical Industries B.V.

16 products tracked · names used in filings: Sun Pharmaceutical Industries B.V., Sun Pharmaceutical Industries Europe B.V., SUN Pharmaceutical Industries (Europe) B.V.

Upcoming milestones

No upcoming milestones listed.

Recent milestones

No recent milestones.

Products

ProductStatusApproved
🇪🇺Ekesivy
diclofenamide
Application withdrawn
🇪🇺Topotecan SUN
topotecan
Application withdrawn
🇪🇺Doxorubicin SUN
doxorubicin
Application withdrawn
🇪🇺Docetaxel SUN
docetaxel
Application withdrawn
🇪🇺Repaglinide Sun
repaglinide
Application withdrawn
🇪🇺Sitagliptin / Metformin hydrochloride Sun
sitagliptin;metformin hydrochloride
Authorised2023-03-31
🇪🇺Teriparatide Sun
teriparatide
Authorised2022-11-18
🇪🇺Ertapenem SUN
ertapenem
Authorised2022-07-15
🇪🇺Sitagliptin SUN
sitagliptin fumarate
Authorised2021-12-09
🇪🇺Bortezomib Sun
bortezomib
Authorised2016-07-22
🇪🇺Odomzo
sonidegib
Authorised2015-08-14
🇪🇺Atosiban SUN
atosiban
Authorised2013-07-31
🇪🇺Capecitabine SUN
capecitabine
Withdrawn2013-06-21
🇪🇺Levetiracetam Sun
levetiracetam
Authorised2011-12-14
🇪🇺Temozolomide Sun
temozolomide
Authorised2011-07-13
🇪🇺Docefrez
docetaxel
Withdrawn2010-05-10

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.